Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Kanamoto

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2012
[Gene therapy for colorectal cancer]Akira Kanamoto, Hideaki Tahara
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerismAkira Kanamoto, Takashi Maki
Transplantation|September 24, 2004
Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusionAkira Kanamoto, Anthony P Monaco, Takashi Maki
Transplantation|November 14, 2007
Splenocytes can replace chimeric cells and maintain allograft toleranceYuuki Hayashi, Shintaro Yamazaki, Akira Kanamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Weekly injection of paclitaxel plus weekly oral administration of cyclophosphamide were very effective for a case of advanced accessory breast cancer]Kimiyasu Yoneyama, Keisuke Hata, Akira Kanamoto, et al.
The Journal of Surgical Research|April 8, 2011
Partially MHC-matched donor CD8+ T cells are indispensable for switching to splenocytic chimerismNaoko Kutsuna, Shintaro Yamazaki, Teruo Kaiga, et al.
The Journal of Surgical Research|April 17, 2012
Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantationNaoko Kutsuna, Shintaro Yamazaki, Teruo Kaiga, et al.
The Journal of Experimental Medicine|May 13, 2009
Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanismsMasahisa Jinushi, Marimo Sato, Akira Kanamoto, et al.
Journal of Translational Medicine|September 17, 2010
Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402Toshiyuki Baba, Marimo Sato-Matsushita, Akira Kanamoto, et al.
Transplantation|March 25, 2008
SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primatesTakashi Maki, Angela Carville, Isaac E Stillman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2012
[Gene therapy for colorectal cancer]Akira Kanamoto, Hideaki Tahara
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerismAkira Kanamoto, Takashi Maki
Transplantation|September 24, 2004
Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusionAkira Kanamoto, Anthony P Monaco, Takashi Maki
Transplantation|November 14, 2007
Splenocytes can replace chimeric cells and maintain allograft toleranceYuuki Hayashi, Shintaro Yamazaki, Akira Kanamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2010
[Weekly injection of paclitaxel plus weekly oral administration of cyclophosphamide were very effective for a case of advanced accessory breast cancer]Kimiyasu Yoneyama, Keisuke Hata, Akira Kanamoto, et al.
The Journal of Surgical Research|April 8, 2011
Partially MHC-matched donor CD8+ T cells are indispensable for switching to splenocytic chimerismNaoko Kutsuna, Shintaro Yamazaki, Teruo Kaiga, et al.
The Journal of Surgical Research|April 17, 2012
Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantationNaoko Kutsuna, Shintaro Yamazaki, Teruo Kaiga, et al.
The Journal of Experimental Medicine|May 13, 2009
Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanismsMasahisa Jinushi, Marimo Sato, Akira Kanamoto, et al.
Journal of Translational Medicine|September 17, 2010
Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402Toshiyuki Baba, Marimo Sato-Matsushita, Akira Kanamoto, et al.
Transplantation|March 25, 2008
SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primatesTakashi Maki, Angela Carville, Isaac E Stillman, et al.
Pageof 2